Corneal wound healing relevance to wavefront guided laser treatments

Ophthalmology Clinics of North America

Volumn 17, Issue 2, 2004, Pages 225-231

  Netto, Marcelo V ^a,b   Wilson, Steven E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CORNEA INJURY; DEVICE; EXCIMER LASER; HUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; SURGICAL TECHNIQUE; WAVEFORM; WOUND HEALING;

CORNEA; CORNEAL TOPOGRAPHY; HUMANS; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; KERATOMILEUSIS, LASER IN SITU; WOUND HEALING;

EID: 2942735359     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2004.03.002     Document Type: Review

References (58)

1. Seiler T., Dastjerdi M.H. Customized corneal ablation. Curr Opin Ophthalmol. 13:2002;256-260
2. MacRae S.M., Williams D.R. Wavefront guided ablation. Am J Ophthalmol. 132:2001;915-919
3. Huang D., Arif M. Spot size and quality of scanning laser correction of higher-order wavefront aberrations. J Cataract Refract Surg. 28:2002;407-416
4. Mrochen M., Eldine M.S., Kaemmerer M., Seiler T., Hutz W. Improvement in photorefractive corneal laser surgery results using an active eye-tracking system. J Cataract Refract Surg. 27:2001;1000-1006
5. Krueger R.R. In perspective: eye tracking and autonomous laser radar. J Refract Surg. 15:1999;145-149
6. Bille J.F. Preoperative simulation of outcomes using adaptive optics. J Refract Surg. 16:2000;S608-S610
7. Seiler T., Mrochen M., Kaemmerer M. Operative correction of ocular aberrations to improve visual acuity. J Refract Surg. 16:2000;S619-S622
8. Durrie D.S. First 100 CustomCornea commercial eyes. J Refract Surg. 19(6):2003;S687-S690
9. Seiler T., Dastjerdi M.H. Customized corneal ablation. Curr Opin Ophthalmol. 13:2002;256-260
10. Mrochen M., Kaemmerer M., Seiler T. Clinical results of wavefront-guided laser in situ keratomileusis 3 months after surgery. J Cataract Refract Surg. 27:2001;201-207
11. Aizawa D., Shimizu K., Komatsu M., Ito M., Suzuki M., Ohno K., et al. Clinical outcomes of wavefront-guided laser in situ keratomileusis: 6-month follow-up. J Cataract Refract Surg. 29:2003;1507-1513
12. Smolek M.K., Klyce S.D. Zernike polynomial fitting fails to represent all visually significant corneal aberrations. Invest Ophthalmol Vis Sci. 44:2003;4676-4681
13. Wilson S.E. Wave-front analysis: are we missing something? Am J Ophthalmol. 136:2003;340-342
14. Alpins N.A. Wavefront technology: a new advance that fails to answer old questions on corneal vs. refractive astigmatism correction. J Refract Surg. 18:2002;737-739
15. Schwiegerling J. Theoretical limits to visual performance. Surv Ophthalmol. 45:2000;139-146
16. Applegate R.A. Limits to vision: can we do better than nature? J Refract Surg. 16:2000;S547-S551
17. Roberts C. Biomechanics of the cornea and wavefront-guided laser refractive surgery. J Refract Surg. 18:2002;S589-S592
18. Ambrosio R. Jr., Netto M.V., Wilson S.E. The future of wavefront technology and corneal ablations. Boyd B., Agarwal A. Wavefront analysis, aberrometers and corneal topography. Highlights of Ophthalmology. 2003;407-422 Highlights of Ophthalmology, Panama City, Panama
19. Wilson S.E., Netto M., Ambrosio R. Jr. Corneal cells: chatty in development, homeostasis, wound healing, and disease. Am J Ophthalmol. 136:2003;530-536
20. Wilson S.E., Mohan R.R., Mohan R.R., Ambrosio R. Jr., Hong J., Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 20:2001;625-637
21. Tervo T., Vesaluoma M., Bennett G.L., Schwall R., Helena M., Liang Q., et al. Tear hepatocyte growth factor (HGF) availability increases markedly after excimer laser surface ablation. Exp Eye Res. 64:1997;501-504
22. Wilson S.E., Liang Q., Kim W.-J. Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci. 40:1999;2185-2190
23. Wilson S.E., Liu J.J. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 18:1999;293-309
24. Wilson S.E., He Y.G., Weng J., Li Q., McDowall A.W., Vital M., et al. Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res. 62:1996;325-327
25. Mohan R.R., Mohan R.R., Kim W.J., Wilson S.E. Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kb. Invest Ophthalmol Vis Sci. 41:2000;1327-1336
26. Wilson S.E., Kim W.J. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 39:1998;220-226
27. Helena M.C., Baerveldt F., Kim W.J., Wilson S.E. Keratocyte apoptosis after corneal surgery. Invest Ophthalmol Vis Sci. 39:1998;276-283
28. Wilson S.E., Li Q., Weng J., Barry-Lane P.A., Jester J.V., Liang Q., et al. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci. 37:1996;1582-1592
29. Mohan R.R., Kim W.J., Mohan R.R., Chen L., Wilson S.E. Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea. Invest Ophthalmol Vis Sci. 39:1998;2626-2636
30. Wilson S.E. Analysis of the keratocyte apoptosis, keratocyte proliferation, and myofibroblast transformation responses after photorefractive keratectomy and laser in situ keratomileusis. Trans Am Ophthalmol Soc. 100:2002;411-433
31. O'Brien T., Li Q., Ashraf M.F., Matteson D.M., Stark W.J., Chan C.C. Inflammatory response in the early stages of wound healing after excimer laser keratectomy. Arch Ophthalmol. 116:1998;1470-1474
32. Mohan R.R., Hutcheon A.E., Choi R., Hong J., Lee J., Mohan R.R., et al. Apoptosis, necrosis, proliferation and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res. 76:2003;71-87
33. Zieske J.D., Guimaraes S.R., Hutcheon A.E. Kinetics of keratocyte proliferation in response to epithelial debridement. Exp Eye Res. 72:2001;33-39
34. Folger P.A., Zekaria D., Grotendorst G., Masur S.K. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation. Invest Ophthalmol Vis Sci. 42:2001;2534-2541
35. Jester J.V., Huang J., Petroll W.M., Cavanagh H.D. TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFbeta, PDGF and integrin signaling. Exp Eye Res. 75:2002;645-657
36. Jester J.V., Moller-Pedersen T., Huang J., Sax C.M., Kays W.T., Cavanagh H.D., et al. The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J Cell Sci. 112:1999;613-622
37. Chalita M.R., Xu M., Krueger R.R. Correlation of aberrations with visual symptoms using wavefront analysis in eyes after laser in situ keratomileusis. J Refract Surg. 19:2003;S682-S686
38. Schwiegerling J., Snyder R.W., Lee J.H. Wavefront and topography: keratome-induced corneal changes demonstrate that both are needed for custom ablation. J Refract Surg. 18:2002;S584-S588
39. Wilson S.E., Ambrosio R. Computerized corneal topography and its importance to wavefront technology. Cornea. 20:2001;441-454
40. Wang L., Wang N., Koch D.D. Evaluation of refractive error measurements of the Wavescan Wavefront system and the Tracey Wavefront aberrometer. J Cataract Refract Surg. 29:2003;970-979
41. Pallikaris I.G., Kymionis G.D., Panagopoulou S.I., Siganos C.S., Theodorakis M.A., Pallikaris A.I. Induced optical aberrations following formation of a laser in situ keratomileusis flap. J Cataract Refract Surg. 28:2002;1737-1741
42. Porter J., MacRae S., Yoon G., Roberts C., Cox I.G., Williams D.R. Separate effects of the microkeratome incision and laser ablation on the eye's wave aberration. Am J Ophthalmol. 136:2003;327-337
43. Kim J.H., Sah W.J., Park C.K., Hahn T.W., Kim M.S. Myopic regression after photorefractive keratectomy. Ophthalmic Surg Lasers. 27(Suppl):1996;435- 439
44. Williams D.K. Multizone photorefractive keratectomy for high and very high myopia: long-term results. J Cataract Refract Surg. 23:1997;1034-1041
45. Ratkay-Traub I., Ferincz I.E., Juhasz T., Kurtz R.M., Krueger R.R. First clinical results with the femtosecond neodynium-glass laser in refractive surgery. J Refract Surg. 19:2003;94-103
46. Pallikaris I.G., Katsanevaki V.J., Kalyvianaki M.I., Naoumidi I.I. Advances in subepithelial excimer refractive surgery techniques: Epi-LASIK. Curr Opin Ophthalmol. 14:2003;207-212
47. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 18:1997;175-184
48. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1:1998;43-50
49. Armstrong R.C., Aja T., Xiang J., Gaur S., Krebs J.F., Hoang K., et al. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem. 12:1996;16, 850-16, 855
50. Rouquet N., Pages J.C., Molina T., Briand P., Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol. 6:1996;1192-1195
51. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 11:1998;1680-1683
52. Jester J.V., Barry-Lane P.A., Petroll W.M., Olsen D.R., Cavanagh H.D. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea. 16:1997;177-187
53. Thom S.B., Myers J.S., Rapuano C.J., Eagle R.C. Jr., Siepser S.B., Gomes J.A. Effect of topical anti-transforming growth factor-beta on corneal stromal haze after photorefractive keratectomy in rabbits. J Cataract Refract Surg. 23:1997;1324-1330
54. Stechschulte S.U., Joussen A.M., von Recum H.A., Poulaki V., Moromizato Y., Yuan J., et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci. 42:2001;1975-1979
55. Kamata Y., Okuyama T., Kosuga M., O'hira A., Kanaji A., Sasaki K., et al. Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII. Mol Ther. 4:2001;307-312
56. Maltseva O., Folger P., Zekaria D., Petridou S., Masur S.K. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest Ophthalmol Vis Sci. 42:2001;2490-2495
57. Cordeiro M.F., Mead A., Ali R.R., Alexander R.A., Murray S., Chen C., et al. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther. 10:2003;59-71
58. Mohan R.R., Schultz G.S., Hong J.W., Mohan R.R., Wilson S.E. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access. Exp Eye Res. 76:2003;373-383